STOCK TITAN

Scinai Immunotherapeutics Ltd. (SCNI) Revenue by Year

SCNI

Scinai Immunotherapeutics Ltd. generated $1.3M in revenue in fiscal year 2025. This represents an increase of 99.2% from the prior fiscal year. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters Scinai Immunotherapeutics Ltd. has filed alongside them.

FY2025 annual
Revenue $1.3M
YoY +99.2%
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

SCNI Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2210-KFY2110-K
Revenue$1.3M+99.2%$658KN/AN/AN/A

SCNI Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2520-FQ2'256-KQ4'2420-FQ2'2410-QQ4'2310-KQ2'2310-QQ1'2310-QQ4'2210-KQ2'2210-QQ1'2210-QQ4'2110-K
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Scinai Immunotherapeutics Ltd. financials

Frequently Asked Questions

What was Scinai Immunotherapeutics Ltd.'s revenue in fiscal year 2025?

Scinai Immunotherapeutics Ltd. generated $1.3M in revenue in fiscal year 2025.

How fast is Scinai Immunotherapeutics Ltd.'s revenue growing?

Scinai Immunotherapeutics Ltd. (SCNI) revenue rose by 99.2% year over year, from $658K to $1.3M in fiscal year 2025.

What does revenue mean on a financial statement?

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Scinai Immunotherapeutics Ltd. (SCNI) reported on that line in every period on record.